Mitsubishi Chemical Group (4188) Q2 2025 earnings summary

Executive summary

• First half FY2024 sales revenue rose 4.3% year-over-year to ¥2,242.1 billion, with core operating income up 44.2% to ¥172.4 billion, driven by strong MMA, display, and pharma demand, but net income attributable to owners fell 39.1% to ¥40.9 billion due to structural reform expenses and special items.

• New management implemented structural reforms, including downsizing coke furnace operations, transferring non-core businesses, and segment reorganization.

• Comprehensive income dropped to ¥14.1 billion from ¥248.9 billion a year earlier, mainly due to negative foreign currency translation effects.

• Display and semiconductor markets showed strong demand in H1, but automotive and food-related markets remained sluggish.

• Focus on sustainable growth with increased production capacity for key materials and a new mid- to long-term management policy in preparation.

Financial highlights

• Sales revenue rose 4% year-on-year to ¥2.421 trillion, with core operating income up 44% year-on-year to ¥172.4 billion.

• Net income attributable to owners of the parent fell 39% year-on-year to ¥40.9 billion due to structural reform expenses and special items.

• Special items totaled minus ¥35.7 billion, including impairment losses and gains on asset sales.

• Operating cash flow was ¥275.1 billion, with free cash flow at ¥129.8 billion.

• EBITDA margin rose to 13.8% in 1H FY2024 from 10.8% in FY2023.

Outlook and guidance

• Full-year FY2024 core operating income forecast raised 16% to ¥290.0 billion, despite a 3% lower sales revenue forecast.

• Net income forecast for FY2024 remains at ¥52.0 billion, unchanged due to expected special item losses in H2.

• Annual dividend forecast maintained at ¥32 per share.

• 2H performance expected to lag initial forecast, especially in Specialty Materials and Basic Materials & Polymers, due to weaker display and semiconductor demand and intensified competition.

• Downward revision in sales and operating income reflects expected demand declines in H2, but robust H1 performance supports higher full-year core operating income.